Pharmaceutical Management Team Visits Nanjing Zhengda Tianqing

Release time:


On September 26 and 27, led by Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, a 16-member management team of Jianfeng Pharmaceutical Co., Ltd. visited Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd.

Nanjing Zhengda Tianqing was established in 2001. By 2018, the company's industrial sales scale reached 4 billion yuan. It is a pharmaceutical company with a similar development process to Jianfeng Pharmaceutical. After more than ten years of development, it has become a "drug research and development, production, and sales". "Trinity, covering the five major treatment fields of cardiovascular and cerebrovascular, oncology, surgery, anesthesia, and anti-infection, is one of the top 100 Chinese medicine companies with comprehensive strength.

The pharmaceutical management team and his party listened to the introduction of Tian Zhoushan, general manager of Zhengda Tianqing, on the basic situation and development process of the enterprise, and visited the research institute and production workshop, focusing on the equipment configuration, workshop design concept, scale and modernization level of each laboratory and workshop. The two sides also communicated on enterprise management, R & D ideas, marketing, R & D incentives and other content. Zhengda Tianqing's development and management experience provide a good reference for Jianfeng Pharmaceutical to better improve its management and scientific research level.

The pharmaceutical management team also visited Nanjing Bai Mai Biotechnology Co., Ltd. This visit and study inspired everyone to find their own gaps and learn from others' strengths.